This year’s recipients of the National Hemophilia Foundation’s (NHF) Clinical Fellowship Program in Bleeding Disorders Research are: Jordan Shavit, MD, PhD, University of Michigan, Ann Arbor, and Michael Callaghan, MD, Children’s Hospital of Michigan. The two-year fellowships, awarded since 2003 and continuing through 2008, are sponsored exclusively by Baxter Healthcare Corporation.
Dr. Shavit received a Bachelor of Science with honors and high distinction in cellular and molecular biology from the University of Michigan, Ann Arbor, in 1992. He earned his MD and PhD degrees from Northwestern University in 2000.
Dr. Callaghan earned his Bachelor of Science from Oakland University in 1997. In 2003 he received his Doctor of Medicine degree from Wayne State University. He completed a pediatric residency program at the Children’s Hospital of Michigan in 2005, where he is a pediatric hematology/oncology fellow.
The clinical fellowship was developed to help educate and train doctors to provide comprehensive care for people with bleeding and clotting disorders, such as hemophilia, von Willebrand disease and thrombophilia.
“NHF is proud to support the training of the next generation of physicians who will treat bleeding and clotting disorders,” said Dr. Alan Kinniburgh, NHF CEO. “This generous sponsorship is an exceptional way for Baxter Healthcare to help sustain high-quality care of individuals with bleeding and clotting disorders.”
Clinical fellows receive tuition reimbursement, medical school loan assistance and hands-on training in clinical care for bleeding disorders. They receive their training at leading hemophilia treatment centers (HTCs) across the country, gaining valuable experience in the latest diagnostic and therapeutic advances and the necessary skills and knowledge to provide comprehensive care.
So far NHF has awarded 13 clinical fellowships through a competitive process. For program information and application materials, go to NHF’s Web site: www.hemophilia.org.